PTPRG and chronic myelogenous leukemia, BCR-ABL1 positive: Epigenetic events, such as hyper-methylation of its promoter region, negatively regulates the transcription of PTPRG, as demonstrated in CML and childhood acute lymphoblastic leukemia [12,13] Re-expression of this protein occurs in the leukocytes of CML patients following targeted therapy [12].